References
- Stiehl A, Raedsch R, Kommerell B. The effect of urso-deoxycholate in primary sclerosing cholangitis. A comparison to primary biliary cirrhosis. Gastroenterology 1988; 94: 595, (abstract)
- Stiehl A, Raedsch R, Rudolph G, Theilmann L. Treatment of primary sclerosing cholangitis with ursodeoxycholic acid: first results of a controlled study. Hepatology 1989; 10: 602, (abstract)
- Hayashi H, Hihucchi T, Ichimiya H. Symptomatic primary sclerosing cholangitis treated with ursodeoxycholic acid. Gastroenterology 1990; 99: 533–5
- Chazouilleres O, Poupon R, Capron J-P. Ursodeoxycholic acid for primary sclerosing cholangitis. J Hepatol 1990; 11: 120–3
- O'Brien C B, Senior J R, Arora-Mirchandi R, Batta A, Salen G. Ursodeoxycholic acid for the treatment of primary sclerosing cholangitis: a 30 months' pilot study. Hepatology 1991; 14: 838–47
- Beuers U, Spengler U, Kruis W. Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: a placebo controlled trial. Hepatology 1992; 16: 707–14
- Stiehl A, Walker S, Stiehl L. Effects of ursodeoxycholic acid on liver and bile duct disease in primary sclerosing cholangitis. A three-year pilot study with a placebo-controlled study period. J Hepatol 1994; 20: 57–64
- Stiehl A, Walker S, Rudolph G, Sauer P, Theilmann L. Survival in patients with PSC treated with ursodeoxycholic acid and by endoscopic dilatations of common duct stenosis: a controlled study. Hepatology 1993; 18: 219A, (abstract)